Bayer AG Logo

Bayer AG

A life science firm providing pharmaceuticals, consumer health, and crop science solutions.

BAY | F

Overview

Corporate Details

ISIN(s):
DE0005752059 (+2 more)
LEI:
549300J4U55H3WP1XT59
Country:
Germany
Address:
Kaiser-Wilhelm-Allee 1, 51373 Leverkusen
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bayer AG is a global life science company with core competencies in healthcare and agriculture. Guided by its mission, "Health for all, Hunger for none," the company develops and commercializes products and services designed to address fundamental human needs and global challenges. Its operations are organized into three divisions: Pharmaceuticals, which focuses on prescription products; Consumer Health, offering over-the-counter medications and supplements; and Crop Science, providing seeds, crop protection, and digital farming solutions. Bayer's portfolio includes numerous world-famous brands and aims to foster innovation in health and nutrition to support a growing and aging global population.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-02 12:09
Declaration of Voting Results & Voting Rights Announcements
English 12.6 KB
2025-08-06 00:00
Interim Report
Half-yearly financial report 2025
English 472.4 KB
2025-08-04 13:55
Major Shareholding Notification
English 86.6 KB
2025-07-31 23:15
Earnings Release
Bayer Aktiengesellschaft: Bayer upgrades currency-adjusted sales and earnings g…
English 12.2 KB
2025-07-24 14:09
Major Shareholding Notification
English 83.7 KB
2025-07-22 11:51
Declaration of Voting Results & Voting Rights Announcements
English 86.3 KB
2025-07-04 07:38
Declaration of Voting Results & Voting Rights Announcements
English 86.4 KB
2025-06-26 15:30
Declaration of Voting Results & Voting Rights Announcements
English 23.5 KB
2025-06-25 12:35
Declaration of Voting Results & Voting Rights Announcements
English 23.5 KB
2025-06-23 13:01
Declaration of Voting Results & Voting Rights Announcements
English 80.3 KB
2025-06-12 12:54
Declaration of Voting Results & Voting Rights Announcements
English 23.5 KB
2025-05-22 09:04
Major Shareholding Notification
English 23.4 KB
2025-05-21 14:01
Major Shareholding Notification
English 18.5 KB
2025-05-19 09:00
Declaration of Voting Results & Voting Rights Announcements
English 23.4 KB
2025-05-17 07:59
Declaration of Voting Results & Voting Rights Announcements
English 18.5 KB

Automate Your Workflow. Get a real-time feed of all Bayer AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bayer AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bayer AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Orum Therapeutics, Inc. Logo
Developing degrader-antibody conjugates for cell-selective protein degradation to treat cancer.
South Korea 475830
OSR Holdings, Inc. Logo
Acquires biopharma R&D platforms to build a diverse portfolio of healthcare therapies.
United States of America OSRH
OS Therapies Inc Logo
Developing a cancer vaccine to treat HER2-expressing tumors, primarily Osteosarcoma.
United States of America OSTX
Otsuka Holdings Co., Ltd. Logo
Global healthcare group creating pharmaceuticals and nutraceuticals for worldwide well-being.
Japan 4578
Outlook Therapeutics, Inc. Logo
Developing an ophthalmic bevacizumab to treat retinal diseases like wet AMD.
United States of America OTLK
Ovid Therapeutics Inc. Logo
Developing targeted small molecule therapies for rare neurological diseases and epilepsies.
United States of America OVID
Ovoca Bio Plc Logo
Biopharma developing a novel therapy for premenopausal women with low sexual desire (HSDD).
Ireland OVXA
Oxford Biomedica PLC Logo
A CDMO for cell & gene therapy, providing end-to-end viral vector development & manufacturing.
United Kingdom OXB
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Logo
A former biopharma firm that developed non-addictive, cannabinoid-based pain therapies.
United Kingdom OCTHF
Pacira BioSciences, Inc. Logo
Advancing non-opioid therapies for postsurgical, chronic, and musculoskeletal pain.
United States of America PCRX

Talk to a Data Expert

Have a question? We'll get back to you promptly.